Abstract
Adult high density lipoprotein-cholesterol (HDL-C), and triglyceride (TG) levels are the product of numerous factors and may significantly influence cardiovascular morbidity. A general aim of pharmacological treatments is that of reducing plasma TG, as well as of increasing HDL-C levels.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Durrington P. N. and Miller I. B. (1985): Atherosclerosis, 55: 187–194.
Eisenberg S. (1984): J. Lipid Res., 25: 1017–1057.
Franceschini G., Montanari G., Cittella C., Colombo L. and Sirtori C. B. (1985): Metabolism, 34: 597–599.
Franceschini G., Sirtori M., Vaccarino V., Gianfranceschi G., Chiesa G. and Sirtori C. R., (1989): J. Lab. Clin. Med., 114: 250–259.
Franceschini G., Sirtori M., Vaccarino V., et al. (1989): Arteriosclerosis, 9: 462–469.
Franceschini G., Bernini F., Michelagnoli S. et al. (1990): Atherosclerosis, 81: 41–49.
Friedman G., Chajek-Shaul T., Stein O. V., Noe L, Etienne J. and Stein Y. (1986): Biochim. Biophys. Acta, 877: 112–120.
Garg A. and Grundy S. M. (1988): N. Engl. J. Med., 318: 81–86.
Johansson J. and Carlson L. A. (1990): Atherosclerosis, 83: 207–216.
Levy R. I., Brensike J. F., Epstein S. E., et al. (1984): Circulation, 69: 325–337.
Luoma P. V. (1988): Pharmacol. Ther., 62: 243–249.
Manninen Y., Huttunen J. K., Heinonen D. P., Tenkanen L. and Frick M. H. (1989): Am. J. Cardiol., 63: 42H–47H.
Patsch J. R, Gotto A. M. Jr, Olivecrona T., Eisenberg S. (1978): Lancet, ii: 391–392.
Saku K., Gartside P., Hynd B. A. and Kashyap M. L. (1985): J. Clin. Invest., 75: 1702–1712.
Schaefer E. G., Levy R. I., Anderson D. W., Danner R. N., Brewer H. B. Jr and Blackwelder W. C. (1978): Lancet, ii: 391–392.
Shepherd J., Packard C. J., Patsch J. R, Gotto A. M. Jr. and Taunton O. D. (1979): J. Clin. Invest., 63: 858–867.
Sirtori C. R, Franceschini G., Gianfranceschi G., Sirtori M., Montanari G., Tremoli E., Maderna P., Colli S., Zoppi F. (1987): J. Lab. Clin. Mad., 110: 279–286.
Sirtori C. R and Franceschini G. (1988): Pharmacol. Ther., 37: 167–191.
Sirtori C. R., Johnson B., Vaccarino V., et al. (1989): Clin. Pharmacol. Ther., 45: 617–626.
Sirtori C. R., Calabresi L., Franceschini G., Gianfranceschini G., Zoppi F., Winkler S., Bilotta P. and Zampetti G. (1990): Atherosclerosis, 84: 203–211.
Taskinen M. R. and Nikkila E. A. (1988): Atherosclerosis, 69: 249–255.
Witztum J. L., Schonfeld G., Weidman S. W., Giese W. E. and Dillingham M. A. (1979): Metabolism, 28: 221–229.
Yamamoto A, Matsuzawa Y., Yokoyama S., Funahashi T., Yamamura T. and Kishino B. (1986): Am. J. Cardiol., 57: 29–35.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Sirtori, C.R. (1992). Drugs Affecting HDL/Triglyceride Levels. In: Gotto, A.M., Lenfant, C., Paoletti, R., Soma, M. (eds) Multiple Risk Factors in Cardiovascular Disease. Medical Science Symposia Series, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2700-4_33
Download citation
DOI: https://doi.org/10.1007/978-94-011-2700-4_33
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5196-5
Online ISBN: 978-94-011-2700-4
eBook Packages: Springer Book Archive